Skip to Content

WATSON 460 (Glipizide 5 mg)

Pill with imprint WATSON 460 is White, Round and has been identified as Glipizide 5 mg. It is supplied by Watson Laboratories, Inc..

Glipizide is used in the treatment of diabetes, type 2 and belongs to the drug class sulfonylureas. Risk cannot be ruled out during pregnancy. Glipizide 5 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for WATSON 460

Glipizide 5 mg WATSON 460
Glipizide 5 mg WATSON 460  Front
Glipizide 5 mg WATSON 460  Back
Glipizide 5 mg WATSON 460
Glipizide 5 mg WATSON 460

Glipizide

Imprint:
WATSON 460
Strength:
5 mg
Color:
White
Size:
8.00 mm
Shape:
Round
Availability:
Prescription only
Drug Class:
Sulfonylureas
Pregnancy Category:
C - Risk cannot be ruled out
CSA Schedule:
Not a controlled drug
Labeler / Supplier:
Watson Laboratories, Inc.
Inactive Ingredients:
silicon dioxide
croscarmellose sodium
lactose anhydrous
microcrystalline cellulose
corn starch
stearic acid
Note: Inactive ingredients may vary.

Other Labelers / Repackagers:

NDC CodeLabeler / Repackager
54569-3841 A-S Medication Solutions, LLC (repackager)
63874-0316 Altura Pharmaceuticals Inc. (repackager)
55289-0806 PDRX Pharmaceuticals Inc. (repackager)
53002-0446 Pharmedix (repackager)

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Hide